University of Texas Health Science Center at Houston Allergy and Immunology

Topics

• Organ Transplantation Techniques and Outcomes 67
• Renal Diseases and Glomerulopathies 59
• Sinusitis and nasal conditions 38
• Hepatocellular Carcinoma Treatment and Prognosis 31
• Asthma and respiratory diseases 25
• Food Allergy and Anaphylaxis Research 25
• Liver Disease and Transplantation 22
• Cholangiocarcinoma and Gallbladder Cancer Studies 21
• Congenital Diaphragmatic Hernia Studies 15
• Hepatitis C virus research 14
• Immune Cell Function and Interaction 14
• SARS-CoV-2 and COVID-19 Research 12

Most cited

1. Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study.

   Lancet (London, England) · 2025 · 275 citations · Mark Ghobrial

2. Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases.

   Kidney international · 2021 · 757 citations · Jonathan Barratt

3. KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV).

   Kidney international · 2025 · 125 citations · Jonathan Barratt

4. Impact of Portable Normothermic Blood-Based Machine Perfusion on Outcomes of Liver Transplant: The OCS Liver PROTECT Randomized Clinical Trial.

   JAMA surgery · 2022 · 394 citations · Mark Ghobrial

5. Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial.

   Lancet (London, England) · 2023 · 272 citations · Jonathan Barratt

6. Sibeprenlimab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial.

   The New England journal of medicine · 2026 · 47 citations ·